John was the Chief Executive Officer and Chairman of Orphan Medical, Inc., a NASDAQ listed specialty pharmaceutical company that developed and marketed eight (8) new drugs to treat rare diseases. He was responsible for the growth of this business from its spin-off until its sale 11 years later to Jazz Pharmaceuticals for nearly $150 million. He was also a co-founder of Chronimed, Inc., a specialty pharmaceutical distribution company, an early Board member of LifeTime Fitness and a Vice President and Partner of FBS Venture Capital Company. He has held Board, financial and operating positions in other small to large companies. He is currently the CEO and Chair of BoundaryMedical, Inc. whose systems allow medical providers to prove clinical outcomes and improve financial performance. John received his MBA from the University of Minnesota Carlson School of Management.